Black Bird Biotech, Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Black Bird Biotech, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2023.
  • Black Bird Biotech, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2023 was 2.5B shares, a 233% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 2.5B +1.75B +233% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 2.5B +1.75B +233% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 2.5B +1.75B +233% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 2.5B 0 0% Dec 31, 2022 10-Q 2023-11-20
Q3 2022 750M +425M +131% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 750M +425M +131% Jun 30, 2022 10-Q 2022-08-23
Q1 2022 750M +425M +131% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 2.5B +2.18B +669% Dec 31, 2021 10-K 2023-03-21
Q3 2021 325M +100M +44.4% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 325M +100M +44.4% Jun 30, 2021 10-Q/A 2021-08-24
Q1 2021 325M +100M +44.4% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 325M 0 0% Dec 31, 2020 10-K 2022-04-15
Q3 2020 225M 0 0% Sep 30, 2020 10-Q 2020-11-23
Q2 2020 225M 0 0% Jun 30, 2020 10-Q/A 2020-08-20
Q1 2020 225M 0 0% Mar 31, 2020 10-Q/A 2020-08-11
Q4 2019 325M +100M +44.4% Dec 31, 2019 10-K 2021-04-15
Q3 2019 225M 0 0% Sep 30, 2019 10-Q 2019-11-20
Q2 2019 225M 0 0% Jun 30, 2019 10-Q 2019-08-19
Q1 2019 225M 0 0% Mar 31, 2019 10-Q 2019-07-30
Q4 2018 225M 0 0% Dec 31, 2018 10-K 2020-07-14
Q3 2018 225M 0 0% Sep 30, 2018 10-Q 2018-11-15
Q2 2018 225M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 225M 0 0% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 225M 0 0% Dec 31, 2017 10-K 2019-05-06
Q3 2017 225M 0 0% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 225M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 225M 0 0% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 225M 0 0% Dec 31, 2016 10-K 2018-04-13
Q3 2016 225M 0 0% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 225M 0 0% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 225M 0 0% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 225M 0 0% Dec 31, 2015 10-K 2017-03-30
Q3 2015 225M 0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 225M 0 0% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 225M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 225M 0 0% Dec 31, 2014 10-K 2016-03-28
Q3 2014 225M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 225M 0 0% Jun 30, 2014 10-Q 2014-08-18
Q1 2014 225M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 225M 0 0% Dec 31, 2013 10-K 2015-03-23
Q3 2013 225M 0 0% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 225M 0 0% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 225M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 225M 0 0% Dec 31, 2012 10-K 2014-04-09
Q3 2012 225M 0 0% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 225M 0 0% Jun 30, 2012 10-Q/A 2012-08-20
Q4 2011 225M 0 0% Dec 31, 2011 10-K 2013-04-15
Q3 2011 225M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 225M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 225M Dec 31, 2010 10-K 2012-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.